SWK Holdings Co. to Issue Dividend of $4.00 (NASDAQ:SWKH)

Market Beat
2025.04.16 22:52
portai
I'm PortAI, I can summarize articles.

SWK Holdings Co. (NASDAQ:SWKH) declared a dividend of $4.00 per share, payable on May 8th to investors of record on April 24th. The ex-dividend date is also April 24th. The company's stock recently traded at $18.01, down 0.2%. SWK reported earnings of $0.54 per share for the last quarter, missing estimates, with revenue of $12.36 million. The company specializes in finance and asset management services, particularly for life science companies.

SWK Holdings Co. (NASDAQ:SWKH - Get Free Report) announced a dividend on Monday, April 14th, NASDAQ Dividends reports. Investors of record on Thursday, April 24th will be given a dividend of 4.00 per share on Thursday, May 8th. The ex-dividend date of this dividend is Thursday, April 24th.

SWK Stock Down 0.2 %

NASDAQ SWKH traded down $0.03 during trading on Monday, reaching $18.01. The company's stock had a trading volume of 26,410 shares, compared to its average volume of 9,977. The business has a 50-day moving average price of $16.83 and a 200-day moving average price of $16.54. SWK has a 1-year low of $15.14 and a 1-year high of $18.78. The stock has a market capitalization of $220.68 million, a PE ratio of 19.37 and a beta of 0.22. The company has a current ratio of 5.06, a quick ratio of 5.06 and a debt-to-equity ratio of 0.11.

SWK (NASDAQ:SWKH - Get Free Report) last posted its earnings results on Wednesday, March 19th. The company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.94 by ($0.40). The company had revenue of $12.36 million for the quarter, compared to the consensus estimate of $9.70 million. SWK had a net margin of 26.51% and a return on equity of 5.07%.

About SWK

(Get Free Report)

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.

Featured Stories

  • Five stocks we like better than SWK
  • How to Buy Gold Stock and Invest in Gold
  • Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
  • What Are Growth Stocks and Investing in Them
  • Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
  • Breakout Stocks: What They Are and How to Identify Them
  • 3 Hot New IPOs Defying the 2025 Market Slump

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SWK Right Now?

Before you consider SWK, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SWK wasn't on the list.

While SWK currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.